We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Medicines Company | NASDAQ:MDCO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 84.90 | 84.00 | 84.94 | 0 | 01:00:00 |
The Medicines Company (NASDAQ:MDCO) today announced that it will host an Investor Day on Tuesday, January 23, 2018, from 10:00 a.m. to 12:30 p.m., Eastern Time, in New York City.
The event will be led by Fred Eshelman, Pharm.D., Executive Chairman of The Medicines Company, and Clive Meanwell, M.D., Ph.D., Chief Executive Officer of the Company, who will be joined by members of the Company’s management team and outside experts and key members of the ORION coalition, including:
Presentations and panel discussions will focus on inclisiran, its highly-differentiated value proposition and clinical and non-clinical development, manufacturing, regulatory and pre-commercial projects, as well as on the continuing, unmet medical and market needs in atherosclerotic cardiovascular disease.
The event will be broadcast live via webcast. To access the live webcast and view the accompanying slide presentation, visit the “Investors - Events/Presentations” section of The Medicines Company website at least 15 minutes before the event is scheduled to begin to register and download or install any necessary software. In addition to the webcast, the event can be accessed, in listen-only mode, as follows:
U.S./Canada: (877) 359-9508 International: (224) 357-2393 Conference ID: 60380330A replay of the webcast will be archived and available after the event for a limited period of time.
The in-person event is reserved for financial analysts and institutional investors and is by invitation only.
About The Medicines Company
The Medicines Company is a biopharmaceutical company driven by an overriding purpose – to save lives, alleviate suffering and contribute to the economics of healthcare. The Company’s mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in serious infectious disease care and cardiovascular care. The Company is headquartered in Parsippany, New Jersey, with a global innovation center in California.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171213005295/en/
The Medicines CompanyMediaMeg Langan, 973-290-6319Vice Presidentmargaret.langan@themedco.comorInvestor RelationsKrishna Gorti, M.D., 973-290-6122Vice President, Investor Relationskrishna.gorti@themedco.com
1 Year Medicines Chart |
1 Month Medicines Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions